Purdue researchers edge closer to delivering personalized medicine to cancer patients

Academic building and snow on the Purdue University campus.

WEST LAFAYETTE, Ind. —

Researchers at Purdue University have developed a technique to better predict chemotherapy resistance in canines and humans.

Chemotherapy can save lives, but often a cancer patient may be resistant to their prescribed chemotherapy, which costs the patient valuable time. Chemoresistance is a topic that researchers need to understand better so that they can match the right type of chemo to the right patient, which is called personalized medicine. 

An unusual pairing of veterinary scientists and physicists at Purdue University believe their method of detecting chemoresistance could be the new standard for personalized medicine. This team is using Doppler ultrasound to detect how cancer cells respond to chemotherapy. They currently have their method of personalized chemotherapy detection in Phase 2 clinical trials in humans at the IU School of Medicine and have also been using the method in canine trials. 

Read more on the Department of Physics and Astronomy website.

Media are encouraged to share, post and publish this content. 

Media contact: Brittany Steff, bsteff@purdue.edu

More Purdue News

Photo of Lars Peter Hansen, 2013 Nobel laureate in economic sciences

University of Chicago professor Lars Hansen, 2013 Nobel laureate in economic sciences, to highlight Purdue Presidential Lecture on Oct. 17

October 2, 2024

Graph depicting farmer sentiment

Farmer sentiment reaches lowest levels since 2016 as income expectations weaken

October 1, 2024

Three women and two men in business attire stand together. One man holds a $20,000 check written to Anu.

Anu wins first place, $20,000 in SCORE’s 60th Anniversary Pitch Competition

October 1, 2024

Three students walk to or from Windsor Halls on Purdue’s campus under a sunny sky

Today’s top 5 from Purdue University

September 27, 2024